You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 17, 2025

Claims for Patent: 10,654,855


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,654,855
Title:Protein kinase B inhibitors
Abstract:The invention relates to a novel group of compounds of Formula (I) or salts thereof:
Inventor(s):Johnson Paul David, Leach Andrew, Luke Richard William Arthur, Matusiak Zbigniew Stanley, Morris Jeffrey James
Assignee:AstraZeneca AB
Application Number:US16028979
Patent Claims: 3. The method according to claim 1 , wherein Z-Zrepresents CH═CH.4. The method according to claim 1 , wherein Rrepresents methoxyCalkyl claim 1 , fluoroCalkyl claim 1 , aminoCalkyl claim 1 , hydroxyCalkyl claim 1 , cyanoCalkyl claim 1 , Ccycloalkyl claim 1 , —(CH)NHCOCH claim 1 , —(CH)NHSOCH claim 1 , —(CH)NHCONH claim 1 , —(CH)NHCONRR claim 1 , —(CH)NRR claim 1 , —(CH)SONH claim 1 , —(CH)CONH claim 1 , —(CH)CONRRor —(CH)—R.5. The method according to wherein Rrepresents —(CH)—P claim 4 , p represents 1 claim 4 , 2 or 3 claim 4 , Ris selected from phenyl claim 4 , piperidinyl claim 4 , piperazinyl claim 4 , pyrrolidinyl claim 4 , morpholinyl claim 4 , imidazolyl claim 4 , isoxazolyl claim 4 , pyrazolyl and thiazolyl and Ris optionally substituted by a single methyl group.6. The method according to claim 1 , wherein Rrepresents hydroxyethyl.7. The method according to claim 1 , wherein Rrepresents chloro or bromo.8. The method according to claim 1 , wherein Rrepresents hydrogen.9. The method according to claim 1 , wherein n is 0 or 1.10. A method of treating breast cancer claim 1 , comprising administering to a person in need thereof a therapeutically effective amount of a pharmaceutical composition comprising: a compound according to claim 1 , or a pharmaceutically-acceptable salt thereof claim 1 , together with a pharmaceutically acceptable diluent or carrier.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.